SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bio_kruncher who wrote (14118)11/15/2004 10:11:45 AM
From: Biomaven  Read Replies (3) of 52153
 
They pointed out that the COX-2's were priority review drugs because of the GI safety issue. Sandy K. stated that at the time of review/approval there were 10,000 annual deaths attributed to NSAID related GI perforation and bleeding.

And to illustrate that this can strike anyone, my 18-year-old niece just got admitted to hospital over the weekend in California with severe anemia. They're doing an endoscopy today, but I'm virtually certain she's had a GI bleed as a result of taking ibuprofen daily over the past 10 days or so for headache and what appeared to be muscle strain resulting from coughing (she had strep throat a few weeks back). Why doctors don't advise you to take OTC Prilosec with NSAIDs is beyond me.

(And now maybe a small rant about her care in a Kaiser facility, given that Kaiser is supposed to be the future of health care in the US. Admitted Friday, but no endoscopy until Monday unless it's an emergency, which this was deemed not to be, although she was a hair-breadth away from needing a transfusion. Didn't start her on Prilosec, although a moderately advanced monkey could see that that was a sensible thing to do. Persisted in trying to draw blood via venipuncture even though she had an IV. etc...)

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News